Abstract
Two effects of the citrus methoxyflavone tangeretin on cell-cell interactions are biologically relevant. Firstly, tangeretin upregulates the function of the E-cadherin/catenin complex in human MCF-7/6 breast carcinoma cells. This leads to firm cell-cell adhesion and inhibition of invasion in vitro. Secondly, tangeretin downregulates the interleukin-2 receptor on T-lymphocytes and natural killer cells. This leads to a decrease in the cytotoxic competence of these immunocytes against cancer cells. The second effect can become important when high doses of tangeretin are combined with adjuvant tamoxifen treatment for breast cancer. Experiments with nude mice bearing MCF-7/6 tumors showed that tangeretin given orally at high doses, abrogated the therapeutic suppression of tumor growth exerted by tamoxifen. No evidence for a tumor promoting effect of tangeretin by itself was found in these experiments. Tangeretin may be an interesting molecule for application in cases where immunosuppression could be clinically beneficial.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bracke, M. E., Bruyneel, E. A., Vermeulen, S. J., Vennekens, K., Van Marck, V., and Mareel, M. M., 1994a, Citrus flavonoid effect on tumor invasion and metastasis, Food Technology 48: 121–124.
Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C., Mareel, M. M., and Castronovo, V., 1994b, Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype, Cancer Res. 54: 4607–4609.
Bracke, M. E., Depypere, H. T., Boterberg, T., Van Marck, V. L., Vennekens, K. M., Vanluchene, E., Nuytinck, M., Serreyn, R. and Mareel, M. M., 1999, Influence of tangeretin on tamoxifen’s therapeutic benefit in mammary cancer, J. Nat!. Cancer Inst. 91: 354–359.
Kemler, R., 1992, Classical cadherins, Semin. Cell Biol. 3: 149–155.
Mareel, M., Berx, G., Van Roy, F., and Bracke, M., 1996a, Cadherin/catenin complex: a target for antiinvasive therapy? J. Cell Biochem. 61: 524–530.
Mareel, M., Noe, V., Vermeulen, S., and Bracke, M., 1996b, Anti-invasive therapy: manipulation of the E-cadherin/catenin/cytoskeleton complex, Anticancer Drugs 7 (Suppl 3): 149–156.
Roitt, I., Brostoff, J., and Male, D., 1998, Cell-mediated immune reactions, In: Immunology, 5th Ed., Roitt, L, Brostoff, J., and Male, D., Eds., Mosby International Ltd, London, pp. 122–123.
Vleminckx, K., Vakaet, L. Jr., Mareel, M., Fiers, W., and Van Roy, F., 1991, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell 66: 107–119.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bracke, M.E., Boterberg, T., Depypere, H.T., Stove, C., Leclercq, G., Mareel, M.M. (2002). The Citrus Methoxyflavone Tangeretin Affects Human Cell-Cell Interactions. In: Buslig, B.S., Manthey, J.A. (eds) Flavonoids in Cell Function. Advances in Experimental Medicine and Biology, vol 505. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5235-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5235-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3383-6
Online ISBN: 978-1-4757-5235-9
eBook Packages: Springer Book Archive